Enterprise Financial Services Corp Charles River Laboratories International, Inc. Transaction History

Enterprise Financial Services Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $286,023 - $365,225	-814 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $296,994 - $365,265	797 Added 4688.24%	814 $336,000
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $2,496 - $2,994	10 Added 142.86%	17 $5,000
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $666 - $757	3 Added 75.0%	7 $2,000
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $395 - $713	4 New	4 $1,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.